Particularly, TP53 is mutated three times more frequently in the normal skin of patients with a high skin cancer burden compared to the low-burden group, indicating that elevated accumulation of UV-signature mutations is associated with an increased burden of cSCC [87]. This evidence concerns the gene TP53 and skin cancer.